πŸ‡ΊπŸ‡Έ FDA
Patent

US 8618290

HSP90 inhibitors

granted A61PA61P1/04A61P11/00

Quick answer

US patent 8618290 (HSP90 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P17/00